Pneumococcal Vaccines Market Report

Europe Pneumococcal Vaccines Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 17, 2019
  • PAGES：216
  • REPORT CODE：GMM383325
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Pneumococcal Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Pneumococcal Vaccines Market Segmentations:

    By Player:

    • Protein Sciences

    • BioCSL (Seqirus)

    • GlaxoSmithKline

    • Sanofi Pasteur

    • Novartis

    • Pfizer

    • Merck

    By Type:

    • 10- valent PCV

    • 7- valent PCV

    • 13- valent PCV

    • 23- valent PPSV

    By End-User:

    • Clinics

    • Hospitals

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pneumococcal Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Pneumococcal Vaccines Market Size and Growth Rate of 10- valent PCV from 2014 to 2026

    • 1.3.2 Europe Pneumococcal Vaccines Market Size and Growth Rate of 7- valent PCV from 2014 to 2026

    • 1.3.3 Europe Pneumococcal Vaccines Market Size and Growth Rate of 13- valent PCV from 2014 to 2026

    • 1.3.4 Europe Pneumococcal Vaccines Market Size and Growth Rate of 23- valent PPSV from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Pneumococcal Vaccines Market Size and Growth Rate of Clinics from 2014 to 2026

    • 1.4.2 Europe Pneumococcal Vaccines Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.3 Europe Pneumococcal Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pneumococcal Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pneumococcal Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of 10- valent PCV

      • 3.4.2 Market Size and Growth Rate of 7- valent PCV

      • 3.4.3 Market Size and Growth Rate of 13- valent PCV

      • 3.4.4 Market Size and Growth Rate of 23- valent PPSV

    4 Segmentation of Pneumococcal Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pneumococcal Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pneumococcal Vaccines for Clinics

      • 4.4.2 Market Size and Growth Rate of Pneumococcal Vaccines for Hospitals

      • 4.4.3 Market Size and Growth Rate of Pneumococcal Vaccines for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Pneumococcal Vaccines Production Analysis by Top Regions

    • 5.2 Europe Pneumococcal Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe Pneumococcal Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Pneumococcal Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Pneumococcal Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Pneumococcal Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pneumococcal Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Pneumococcal Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Pneumococcal Vaccines Landscape Analysis

    • 7.1 Germany Pneumococcal Vaccines Landscape Analysis by Major Types

    • 7.2 Germany Pneumococcal Vaccines Landscape Analysis by Major End-Users

    8. UK Pneumococcal Vaccines Landscape Analysis

    • 8.1 UK Pneumococcal Vaccines Landscape Analysis by Major Types

    • 8.2 UK Pneumococcal Vaccines Landscape Analysis by Major End-Users

    9. France Pneumococcal Vaccines Landscape Analysis

    • 9.1 France Pneumococcal Vaccines Landscape Analysis by Major Types

    • 9.2 France Pneumococcal Vaccines Landscape Analysis by Major End-Users

    10. Italy Pneumococcal Vaccines Landscape Analysis

    • 10.1 Italy Pneumococcal Vaccines Landscape Analysis by Major Types

    • 10.2 Italy Pneumococcal Vaccines Landscape Analysis by Major End-Users

    11. Spain Pneumococcal Vaccines Landscape Analysis

    • 11.1 Spain Pneumococcal Vaccines Landscape Analysis by Major Types

    • 11.2 Spain Pneumococcal Vaccines Landscape Analysis by Major End-Users

    12. Poland Pneumococcal Vaccines Landscape Analysis

    • 12.1 Poland Pneumococcal Vaccines Landscape Analysis by Major Types

    • 12.2 Poland Pneumococcal Vaccines Landscape Analysis by Major End-Users

    13. Russia Pneumococcal Vaccines Landscape Analysis

    • 13.1 Russia Pneumococcal Vaccines Landscape Analysis by Major Types

    • 13.2 Russia Pneumococcal Vaccines Landscape Analysis by Major End-Users

    14. Switzerland Pneumococcal Vaccines Landscape Analysis

    • 14.1 Switzerland Pneumococcal Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland Pneumococcal Vaccines Landscape Analysis by Major End-Users

    15. Turkey Pneumococcal Vaccines Landscape Analysis

    • 15.1 Turkey Pneumococcal Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey Pneumococcal Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Pneumococcal Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland Pneumococcal Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway Pneumococcal Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden Pneumococcal Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland Pneumococcal Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Pneumococcal Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands Pneumococcal Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Pneumococcal Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Pneumococcal Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia Pneumococcal Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania Pneumococcal Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Protein Sciences

      • 19.1.1 Protein Sciences Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 BioCSL (Seqirus)

      • 19.2.1 BioCSL (Seqirus) Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GlaxoSmithKline

      • 19.3.1 GlaxoSmithKline Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sanofi Pasteur

      • 19.4.1 Sanofi Pasteur Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Novartis

      • 19.5.1 Novartis Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pfizer

      • 19.6.1 Pfizer Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Merck

      • 19.7.1 Merck Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    The List of Tables and Figures (Totals 85 Figures and 157 Tables)

    • Figure Product Picture

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of 10- valent PCV from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of 7- valent PCV from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of 13- valent PCV from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of 23- valent PPSV from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pneumococcal Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pneumococcal Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pneumococcal Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Pneumococcal Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of 10- valent PCV

    • Figure Market Size and Growth Rate of 7- valent PCV

    • Figure Market Size and Growth Rate of 13- valent PCV

    • Figure Market Size and Growth Rate of 23- valent PPSV

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pneumococcal Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pneumococcal Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Others

    • Table Europe Pneumococcal Vaccines Production by Major Regions

    • Table Europe Pneumococcal Vaccines Production Share by Major Regions

    • Figure Europe Pneumococcal Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe Pneumococcal Vaccines Consumption by Major Regions

    • Table Europe Pneumococcal Vaccines Consumption Share by Major Regions

    • Table Germany Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table UK Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table France Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Germany Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table UK Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table France Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table France Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table France Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Italy Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Spain Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Poland Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Russia Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Protein Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protein Sciences

    • Figure Sales and Growth Rate Analysis of Protein Sciences

    • Figure Revenue and Market Share Analysis of Protein Sciences

    • Table Product and Service Introduction of Protein Sciences

    • Table Company Profile and Development Status of BioCSL (Seqirus)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCSL (Seqirus)

    • Figure Sales and Growth Rate Analysis of BioCSL (Seqirus)

    • Figure Revenue and Market Share Analysis of BioCSL (Seqirus)

    • Table Product and Service Introduction of BioCSL (Seqirus)

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Sanofi Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur

    • Table Product and Service Introduction of Sanofi Pasteur

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US